Free Trial
→ Bill Gates’ is about to mint millionaires (again) with Stargate. (From Brownstone Research) (Ad) Free FDMT Stock Alerts

4D Molecular Therapeutics (FDMT) SEC Filings & 10K Form

4D Molecular Therapeutics logo
$4.58 -0.10 (-2.14%)
As of 04:00 PM Eastern
Compare

Recent 4D Molecular Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
01/10/2025
7:36 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:15 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:05 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:15 PM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
8:13 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/13/2024
3:33 PM		4D Molecular Therapeutics (Issuer)
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:17 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:08 PM		4D Molecular Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
11/12/2024
11:12 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
1:17 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
11/06/2024
5:07 PM		4D Molecular Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G
11/04/2024
9:55 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/21/2024
3:11 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
09/18/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:06 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:22 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:13 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:17 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
4:11 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM		4D Molecular Therapeutics (Subject)
Bizily Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:07 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:44 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144/A
06/24/2024
4:39 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
4:04 PM		4D Molecular Therapeutics (Filer)
Form 424B5
06/07/2024
4:07 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
7:45 PM		4D Molecular Therapeutics (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:10 PM		4D Molecular Therapeutics (Issuer)
GRAY SUSANNAH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:11 PM		4D Molecular Therapeutics (Issuer)
MILLIGAN JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:12 PM		4D Molecular Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:16 PM		4D Molecular Therapeutics (Issuer)
THEUER CHARLES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:17 PM		4D Molecular Therapeutics (Issuer)
Chacko Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:35 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:22 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:09 PM		4D Molecular Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/18/2024
7:48 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:05 PM		4D Molecular Therapeutics (Filer)
Form DEF 14A
04/10/2024
3:06 PM		4D Molecular Therapeutics (Filer)
Form DEFA14A
04/10/2024
3:07 PM		4D Molecular Therapeutics (Filer)
Form ARS
04/03/2024
6:18 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:52 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
3:40 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:01 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:15 PM		4D Molecular Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2024
4:41 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:51 PM		4D Molecular Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/14/2024
8:56 AM		4D Molecular Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/14/2024
7:43 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
02/13/2024
9:56 AM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/12/2024
8:04 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
7:22 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:50 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
7:32 PM		4D Molecular Therapeutics (Issuer)
Kim Robert Young (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:42 PM		4D Molecular Therapeutics (Issuer)
Kim Robert Young (Reporting)
Form 3/A
02/05/2024
4:27 PM		4D Molecular Therapeutics (Filer)
Form 424B5
02/05/2024
3:35 PM		4D Molecular Therapeutics (Filer)
Form S-3ASR
01/25/2024
3:59 PM		4D Molecular Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/23/2024
3:50 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:FDMT) was last updated on 1/17/2025 by MarketBeat.com Staff
From Our Partners
I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Stunning Trump Exec Order Leaked
This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...
Banyan Hill Publishing | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode in 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...
Brownstone Research | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...
Crypto Swap Profits | Sponsored
liberals FOOLED by Elon’s shocking surprise
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...
StocksToTrade | Sponsored